Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | GAPDH | P04406 | 2/20 | 0.40 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.37 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23624636 | 0.86 | TYMP (0.44) | TAS1R3TAS1R1KDM4EGAPDHP2RY12 | |
| SCHEMBL20248745 | 0.86 | TAS1R3 (0.42) | TAS1R3TAS1R1KDM4EP2RY12DNPH1 | |
| SCHEMBL23624816 | 0.86 | P2RY12 (0.49) | ADORA3GAPDHP2RY12DNPH1 | |
| SCHEMBL17860500 | 0.84 | TAS1R3 (0.41) | TAS1R3TAS1R1KDM4EGAPDHP2RY12 | |
| SCHEMBL18490411 | 0.83 | KDM4E (0.40) | TAS1R3TAS1R1KDM4EGAPDHP2RY12 | |
| SCHEMBL18497652 | 0.83 | KDM4E (0.46) | TAS1R3TAS1R1KDM4EGAPDHP2RY12 | |
| SCHEMBL20341117 | 0.83 | TAS1R3 (0.41) | TAS1R3TAS1R1KDM4EGAPDHP2RY12 | |
| SCHEMBL22301419 | 0.83 | KDM4E (0.39) | TAS1R3TAS1R1KDM4EGAPDHP2RY12 | |
| SCHEMBL22301424 | 0.83 | KDM4E (0.39) | TAS1R3TAS1R1KDM4EGAPDHP2RY12 | |
| SCHEMBL17860560 | 0.82 | KDM4E (0.40) | TAS1R3TAS1R1KDM4EGAPDHP2RY12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11597932-B2 | Chirally-enriched double-stranded RNA agents | ALNYLAM PHARMACEUTICALS, INC. (US) | 2023-03-07 | — | — | US | disclosed |
| US-20210207144-A1 | CHIRALLY-ENRICHED DOUBLE-STRANDED RNA AGENTS | BANK OF AMERICA, N.A. | 2021-07-08 | — | — | US | disclosed |